当前位置: 首页 > 详情页

Role for Granulocyte Colony Stimulating Factor in Angiotensin II-Induced Neutrophil Recruitment and Cardiac Fibrosis in Mice

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Minist Educ, Sch Basic Med Sci, Dept Pathol & Pathophysiol,Key Lab Remodeling Rel, Beijing, Peoples R China; [2]Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Minist Educ,Key Lab Remodeling Related Cardiovasc, Beijing, Peoples R China
出处:
ISSN:

关键词: angiotensin II blood pressure cardiac fibrosis granulocyte colony stimulating factor hypertension neutrophils

摘要:
BACKGROUND Granulocyte colony stimulating factor (G-CSF) is a key mediator of neutrophil infiltration and is profibrotic in the liver, lung, and infarcted heart, but its roles in angiotensin II (Ang II)-induced hypertension and cardiac remodeling have not been fully determined. Thus, we sought to investigate the causal relation of G-CSF to neutrophil recruitment and cardiac fibrosis in C57BL/6J mice. METHODS Hypertension and cardiac fibrosis were induced in wild-type (WT) mice receiving continuous infusion of Ang II (1,500 ng/kg/min). After 7 days, heart sections were stained with hematoxylin and eosin, Masson's trichrome, and immunohistochemistry. The mRNA expression of cytokines was detected by real-time polymerase chain reaction analysis. The protein levels were measured by Western blot analysis. RESULTS After Ang II infusion, myocardial G-CSF expression was significantly elevated in the hearts. Moreover, WT mice exhibited increased blood pressure, marked neutrophil accumulation, proinflammatory cytokine expression, reactive oxygen species production, and cardiac fibrosis after 7 days of Ang II infusion. However, administration of anti-G-CSF neutralizing antibody, but not with control immunoglobulin G, significantly attenuated these effects. In addition, neutralizing G-CSF antibody reversed Ang II-induced activation of ERK1/2, STAT3, and AKT signaling pathways in the hearts. CONCLUSIONS This study demonstrates that G-CSF plays a critical role in hypertension and cardiac fibrosis and targeting this cytokine may be a novel therapeutic strategy to ameliorate hypertensive heart disease.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2012]版:
大类 | 3 区 医学
小类 | 3 区 外周血管病
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 外周血管病
JCR分区:
出版当年[2011]版:
Q1 PERIPHERAL VASCULAR DISEASE
最新[2023]版:
Q2 PERIPHERAL VASCULAR DISEASE

影响因子: 最新[2023版] 最新五年平均 出版当年[2011版] 出版当年五年平均 出版前一年[2010版] 出版后一年[2012版]

第一作者:
第一作者机构: [1]Capital Med Univ, Minist Educ, Sch Basic Med Sci, Dept Pathol & Pathophysiol,Key Lab Remodeling Rel, Beijing, Peoples R China;
通讯作者:
通讯机构: [1]Capital Med Univ, Minist Educ, Sch Basic Med Sci, Dept Pathol & Pathophysiol,Key Lab Remodeling Rel, Beijing, Peoples R China;
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院